Reportable Segment Information (Tables)

9 Months Ended

Jun. 30, 2016

Segment Reporting [Abstract]

Segment Revenue, Operating Income and Depreciation and Amortization

The table below presents segment revenue, operating income and depreciation and amortization, as follows:

	Three Months Ended						Nine Months Ended
	June 30,						June 30,
(Dollars in thousands)	2016			2015			2016			2015
Revenue:
Medical Device	$	15,654		$	11,629		$	39,500		$	32,827
In Vitro Diagnostics		4,318			4,285			13,712			11,708
Total revenue	$	19,972		$	15,914		$	53,212		$	44,535
Operating income:
Medical Device	$	6,673		$	6,295		$	12,825		$	16,507
In Vitro Diagnostics		1,673			1,191			5,298			3,220
Total segment operating income		8,346			7,486			18,123			19,727
Corporate		(1,749	)		(1,629	)		(5,347	)		(4,903	)
Total operating income	$	6,597		$	5,857		$	12,776		$	14,824
Depreciation and amortization:
Medical Device	$	982		$	288		$	2,440		$	852
In Vitro Diagnostics		222			215			647			645
Corporate		202			191			616			586
Total depreciation and amortization	$	1,406		$	694		$	3,703		$	2,083